Hao Zhichao, Guo Yuqi, Bowling Jessamyn, Ledenyi Madeleine
College of State Governance, Southwest University, Chongqing, China.
School of Social Work, University of North Carolina at Charlotte, Charlotte, NC, USA.
Int J Sex Health. 2021 Oct 16;34(2):291-307. doi: 10.1080/19317611.2021.1989535. eCollection 2022.
This study aims to identify facilitators and barriers of Human Papillomavirus (HPV) vaccine acceptance, initiation, and completion among LGBTQ (lesbian, gay, bisexual, trans, and queer) individuals. A systematic review of qualitative and quantitative studies on HPV vaccine acceptance, initiation, and completion from 2006 to June 15, 2020 was performed in each database. Twenty-six studies focusing on HPV vaccination among LGBTQ individuals were reviewed. Knowledge of HPV vaccine and healthcare providers' recommendations were identified as facilitators to receive HPV vaccinate, while high co-pay cost and concerns of the effectiveness and safety were identified as barriers.
本研究旨在确定在女同性恋、男同性恋、双性恋、跨性别者和酷儿(LGBTQ)群体中,人乳头瘤病毒(HPV)疫苗接受、开始接种和全程接种的促进因素和障碍。在每个数据库中对2006年至2020年6月15日期间关于HPV疫苗接受、开始接种和全程接种的定性和定量研究进行了系统综述。对26项关注LGBTQ群体HPV疫苗接种的研究进行了综述。HPV疫苗知识和医疗保健提供者的建议被确定为接受HPV疫苗接种的促进因素,而高额的自付费用以及对有效性和安全性的担忧则被确定为障碍。
Infect Dis Rep. 2021-10-7
Vaccines (Basel). 2022-5-20
Health Educ J. 2017-2